These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17223552)

  • 1. Caffeine decreases vitamin D receptor protein expression and 1,25(OH)2D3 stimulated alkaline phosphatase activity in human osteoblast cells.
    Rapuri PB; Gallagher JC; Nawaz Z
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):368-71. PubMed ID: 17223552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
    Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
    J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts.
    Willems HM; van den Heuvel EG; Carmeliet G; Schaafsma A; Klein-Nulend J; Bakker AD
    Steroids; 2012 Jan; 77(1-2):126-31. PubMed ID: 22093484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
    Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
    J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3).
    Chen J; Doroudi M; Cheung J; Grozier AL; Schwartz Z; Boyan BD
    Cell Signal; 2013 Dec; 25(12):2362-73. PubMed ID: 23896121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel interaction between insulin-like growth factor binding protein-6 and the vitamin D receptor inhibits the role of vitamin D3 in osteoblast differentiation.
    Cui J; Ma C; Qiu J; Ma X; Wang X; Chen H; Huang B
    Mol Cell Endocrinol; 2011 May; 338(1-2):84-92. PubMed ID: 21458526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
    Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor.
    Li J; Jin D; Fu S; Mei G; Zhou J; Lei L; Yu B; Wang G
    Biochem Biophys Res Commun; 2013 Jul; 436(4):632-7. PubMed ID: 23770368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
    Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
    Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25(OH)2D3 inhibits the deleterious effects induced by high glucose on osteoblasts through undercarboxylated osteocalcin and insulin signaling.
    Wu YY; Yu T; Zhang XH; Liu YS; Li F; Wang YY; Wang YY; Gong P
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):112-9. PubMed ID: 22595150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
    Yamaguchi M; Weitzmann MN
    Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
    Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
    J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17 beta-estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells.
    Ishibe M; Nojima T; Ishibashi T; Koda T; Kaneda K; Rosier RN; Puzas JE
    Calcif Tissue Int; 1995 Dec; 57(6):430-5. PubMed ID: 8581875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
    Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
    J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
    Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
    Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
    Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.